Daniel A. Camardo, EVP and President, U.S. at Horizon Therapeutics, holds 285.34K shares in Athersys (Ticker: ATHXQ), holds 51.18K shares in Horizon Therapeutics (Ticker: HZNP).

See the Hottest Stocks Based on Insider Trading >

Daniel A. Camardo
Horizon Therapeutics (HZNP)
EVP and President, U.S.

Ranked #80,332 out of 98,743 Corporate Insiders

Profitable Transactions

1 out of 3 Profitable Transactions

Average Return

-31.80%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

ATHXQ

A breakdown of Daniel A. Camardo's holdings

See the Top Stocks by Insiders

Insider Roles

Athersys
(ATHXQ)

CEO, Director

Roles that Daniel A. Camardo holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Horizon Therapeutics
(HZNP)

Rating:Informative Buy

Date:Apr 05, 2021 - Apr 05, 2022

Return:+18.30%

The most profitable trade made by Daniel A. Camardo

See the Latest Stocks Traded by Insiders

Daniel A. Camardo's Trading History

HZNP

Horizon Therapeutics

Apr 05, 2021

―

Informative Buy

442.09K

$5.95M

ATHXQ

Athersys

Oct 06, 2023

CEO, Director

Uninformative Sell

8.80K

$2.85K

List of latest transactions for each holding click on a transaction to see Daniel A. Camardo's performance on stock

See All Insider Trading from Today

Daniel A. Camardo insider profile FAQ

What is the percentage of profitable transactions made by Daniel A. Camardo?

The percentage of profitable transactions made by Daniel A. Camardo is 33%.

What is the average return per transaction made by Daniel A. Camardo?

The average return per transaction made by Daniel A. Camardo is -31.80%.

What stocks does Daniel A. Camardo hold?

Daniel A. Camardo holds: HZNP, ATHXQ stocks.

What was Daniel A. Camardo’s latest transaction?

Daniel A. Camardo latest transaction was an Uninformative Sell of $8.80K.

What was Daniel A. Camardo's most profitable transaction?

Daniel A. Camardo’s most profitable transaction was an Informative Buy of HZNP stock on April 5, 2021. The return on the trade was 18.30%.

What is Daniel A. Camardo's role in Horizon Therapeutics?

Daniel A. Camardo's role in Horizon Therapeutics is EVP and President, U.S..

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Daniel A. Camardo Insider Profile

Daniel A. Camardo Horizon Therapeutics (HZNP)EVP and President, U.S.